Preview

User

Not a user? Register with this site Forgot your password?

Cancer Urology

Advanced search
Fullscreen

For citations:

Kirichek A.A., Sokolov E.A., Lebedev S.S., Tsedenova K.O. Efficacy of cabozantinib in the 1st line therapy of progressing multiple primary metachronous renal cell carcinomas: clinical observation. Cancer Urology. 2025;21(2):153-166. (In Russ.) https://doi.org/10.17650/1726-9776-2025-21-2-153-166

Views PDF (Rus): 6


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1726-9776 (Print)
ISSN 1996-1812 (Online)

“ABV-press” publishing house
Research Institute of Carcinogenesis
Floor 3, 24 Kashirskoe Shosse, Build. 15,
Moscow 115478, Russian Federation
tel. +7 (499) 929-96-19,
E-mail: abv@abvpress.ru

Processing of personal data
supported by NEICON (Elpub lab)
X